Bausch + Lomb Highlights LUMIFY's Role in Addressing Rising Ocular Redness
Event summary
- Ophthalmology and Therapy published a global narrative review on noninfectious conjunctival hyperemia (ocular redness), highlighting its rising prevalence due to digital lifestyles, dry eye, and environmental factors.
- The review underscores the aesthetic and psychosocial impact of ocular redness, noting its effects on perceived health and fatigue, especially in the era of video conferencing and social media.
- Brimonidine tartrate 0.025% (LUMIFY) demonstrated effective redness reduction with no tachyphylaxis over 29 days and virtually no rebound redness after discontinuation.
- LUMIFY Preservative Free Eye Drops were introduced in 2025, offering an additional brimonidine-based option without preservatives.
- LUMIFY holds over 60% market share and is the No. 1 eye doctor-recommended redness reliever eye drop brand.
The big picture
The publication of the global narrative review underscores the strategic importance of LUMIFY in addressing a lifestyle-driven health issue. As digital lifestyles and environmental factors continue to drive the prevalence of ocular redness, Bausch + Lomb's focus on selective mechanisms and favorable safety profiles positions it well to capitalize on the growing demand for effective and safe redness-relief products. The introduction of LUMIFY Preservative Free further expands its product offerings, reinforcing its commitment to innovation and consumer health.
What we're watching
- Market Leadership
- Whether Bausch + Lomb can sustain LUMIFY's dominant market position amid increasing global self-treatment and concerns with unsafe or unapproved copycat products.
- Consumer Preferences
- How the growing demand for safe, aesthetically minded OTC products will shape the future of ocular redness management.
- Regulatory Landscape
- The pace at which regulatory bodies will address the proliferation of counterfeit or unapproved redness relievers, impacting consumer safety and market dynamics.
Related topics